Practical Guide to Building

The Sponsor Oversight Trifecta: Budget Intelligence, Risk-Based Monitoring, and Strategic Review for 2026

Executive summary In 2025, clinical trial success hinged less on protocol design and more on how sponsors managed oversight.  An updated analysis from the  Tufts Center for the Study of Drug Development estimates the average daily direct cost of a trial at $40,000 per day (Phase III:$55,716), indicating that fragmented oversight is no longer sustainable. The finalized […]

Learn More